41 Targeting IL-23 Activated dendritic cells can induce proliferation of Th1 and Th2 cells
It has been investigated in preclinical and clinical models for: Sexual desire and performance Hypoactive sexual desire disorder (HSDD) Mood, appetite, and circadian rhythm modulation Applications in Research: Studies involving sexual function and central arousal pathways Investigations into melanocortin signaling and neural circuits Research on mood regulation, feeding behavior, and energy homeostasis Exploratory studies in neuroendocrinology and reward pathways Storage & Handling: Store lyophilized PT-141 at -20C, protected from light and moisture
Rootcology Carnitine Blend is gluten free, dairy free, soy free, pesticide free, non-GMO, and shellfish free
For example, in the study by Peng et al

Metabolic Syndrome Resolution Post-hoc analysis of SURPASS trials demonstrated substantial reductions in metabolic syndrome prevalence: Significant improvements in multiple cardiovascular risk factors simultaneously Reductions in blood pressure, improved lipid profiles, and decreased waist circumference Resolution of metabolic syndrome criteria in a substantial proportion of participants Potential long-term cardiovascular benefits from comprehensive metabolic improvements Cardiovascular and Metabolic Comorbidities Heart Failure with Preserved Ejection Fraction (HFpEF) The SUMMIT phase 3 trial evaluated GLP2 in adults with HFpEF and obesity: Statistically significant reduction in heart failure outcomes (composite endpoint) Improvements in heart failure symptoms and physical limitations measured by Kansas City Cardiomyopathy Questionnaire Enhanced exercise capacity as measured by 6-Minute Walk Test Distance Reduction in high-sensitivity C-reactive protein (inflammation marker) These findings established GLP2 as the first incretin therapy to demonstrate benefits on heart failure outcomes in this population

While the weight loss results are impressive, Retatrutides benefits go much deeper